2370 — MEDINET Co Balance Sheet
0.000.00%
- ¥8bn
- ¥5bn
- ¥810m
Annual balance sheet for MEDINET Co, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4,096 | 4,499 | 4,396 | 4,651 | 3,170 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 219 | 171 | 217 | 228 | 256 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,405 | 4,807 | 4,769 | 5,013 | 3,612 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 620 | 537 | 478 | 423 | 357 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,378 | 6,078 | 5,634 | 5,700 | 4,254 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 275 | 279 | 347 | 269 | 233 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 475 | 566 | 590 | 509 | 476 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 4,903 | 5,512 | 5,044 | 5,191 | 3,778 |
| Total Liabilities & Shareholders' Equity | 5,378 | 6,078 | 5,634 | 5,700 | 4,254 |
| Total Common Shares Outstanding |